Home › NDC Lookup › RxCUI directory › RxCUI 2684952

Elafibranor 80 MG Oral Tablet [Iqirvo] — RxCUI 2684952

RxNorm drug concept · Semantic branded drug
RxCUI 2684952 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2684952
Official nameElafibranor 80 MG Oral Tablet [Iqirvo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asIqirvo 80 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)383 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Elafibranor: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Primary biliary cholangitis (PBC) is a chronic liver disease where your immune system gradually damages the small bile ducts inside your liver. Over time, bile builds up and can ca...
  • What exactly is primary biliary cholangitis, and why do I need this medication?
  • You take one Iqirvo tablet by mouth once a day, and you can take it with or without food — both are fine. If you eat a high-fat meal it may slow down how quickly the drug is absorb...
  • How should I take Iqirvo, and does it matter if I take it with food?
📖 Read our full Elafibranor guide →

🕸️ Concept Web — How Elafibranor 80 MG Oral Tablet [Iqirvo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Elafibranor 80 MG Oral Tablet [Iqirvo] RxCUI 2684952

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Elafibranor 2684941
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Iqirvo 2684947
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Elafibranor Oral Tablet 2684945
    • Elafibranor Oral Product 2684943
    • Elafibranor Pill 2684944
    • Elafibranor Oral Tablet [Iqirvo] 2684951
    • Iqirvo Oral Product 2684949
    • Iqirvo Pill 2684950
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Elafibranor 80 MG Oral Tablet SCD · 2684946
  • Elafibranor 80 MG SCDC · 2684942
  • Elafibranor Oral Tablet SCDF · 2684945
  • Elafibranor Oral Product SCDG · 2684943
  • Elafibranor Pill SCDG · 2684944

Brand-Name Concepts

  • Elafibranor 80 MG [Iqirvo] SBDC · 2684948
  • Elafibranor Oral Tablet [Iqirvo] SBDF · 2684951
  • Iqirvo Oral Product SBDG · 2684949
  • Iqirvo Pill SBDG · 2684950
  • Iqirvo BN · 2684947

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2684952 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
15054-0080-01 1 BOTTLE in 1 CARTON (15054-0080-1) / 30 TABLET, FILM COATE... IQIRVO Ipsen Biopharmaceuticals, Inc. 2024-06-10
Observed labelers: Ipsen Biopharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.